Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Robo Global Healthcare Technology and Innovation ETF (HTEC) belongs to the Multiple Trends segment. T. Rowe Price Health Care ETF (TMED) is part of the US Health Care segment. HTEC's top 3 sector exposures are Health Care, Consumer Discretionary and Information Technology. In contrast, TMED's top sector exposures are Health Care, Financials HTEC is more expensive with a Total Expense Ratio (TER) of 0.8%, versus 0.44% for TMED. HTEC is down -7.48% year-to-date (YTD) with - in YTD flows. TMED performs better with -2.36% YTD performance, and +$3M in YTD flows. Run a side-by-side ETF comparison of HTEC and TMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | HTEC TMED | -7.21%-2.09% | -6.60%-1.63% | -7.48%-2.36% | +17.11%n/a | +13.30%n/a | -25.71%n/a |
| Flows | HTEC TMED | -+$1M | -+$3M | -+$3M | -$4M- | -$54M- | -$82M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | HTEC TMED | +18.04%+17.63% | +22.01%n/a | +19.91%n/a | +23.78%n/a |
| Max drawdown | HTEC TMED | -15.11%-7.97% | -15.36%n/a | -28.61%n/a | -56.05%n/a |
| Max drawdown duration | HTEC TMED | 53d53d | 99dn/a | 546dn/a | 1656dn/a |
HTEC | TMED | |
Last sale 3/18/2026 at 1:30 PM | $32.49 | $28.47 |
| Previous close 03/17/2026 | $33.14 | $28.90 |
| Consolidated volume 03/17/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
HTEC | TMED | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
HTEC | TMED | |
|---|---|---|
| Last price | $32.49 | $28.47 |
| 1D performance | -1.96% | -1.50% |
| AuM | $49.20 M | $18.84 M |
| E/R | 0.8% | 0.44% |
HTEC | TMED | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | ROBO Global ETFs | T. Rowe Price |
| Benchmark | ROBO Global Healthcare Technology and Innovation | - |
| N° of holdings | 58 | 74 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 25, 2019 | June 11, 2025 |
| ESG | Yes | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
